Calderon, Jaden S.

HRN: 29-33-89  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/21/2026
07/28/2026
IV
390
Q 6
T/C UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: